Chronic obstructive pulmonary disease (COPD) patients often face psychological and neuropsychological problems that affect pulmonary rehabilitation outcomes. The prevalence of certain factors, including depressive symptoms, anxiety, mild cognitive impairment (MCI), and self-reported adherence, can assist in predicting patient adherence to prescribed physical exercise and diet.
Chronic obstructive pulmonary disease (COPD) patients often face psychological and neuropsychological problems that affect pulmonary rehabilitation outcomes. The prevalence of certain factors, including depressive symptoms, anxiety, mild cognitive impairment (MCI), and self-reported adherence, can assist in predicting patient adherence to prescribed physical exercise and diet.
According to a study published in the International Journal of Chronic Obstructive Pulmonary Disease, pulmonary rehabilitation can decrease symptoms and disability while increasing physical and social activity participation to improve the overall health-related quality of life (HRQoL) in COPD patients. The study’s eligible participants were admitted to an inpatient comprehensive rehabilitation program, where each patient was involved in an individual assessment.
The study’s psychological and neuropsychological assessment included the Hospital Anxiety and Depression Scale; the 30-point Geriatric Depression Scale; the Beck Depression Inventory; the Morisky, Green, and Levine Adherence Scale; the Adherence Schedule in Chronic Obstructive Lung Disease (ASiCOLD) — Revised; the MMSE21; and the Montreal Cognitive Assessment.
Of the 84 patients included in the study, 46.7% of patients had mild-severe depression and 40.5% suffered from anxiety. Depression was determined to be related to autonomous long-term oxygen therapy modifications, disease perception, family support, and MCI.
In addition, 80.3% were considered to have good pharmacological adherence; however, 24.1% had trouble following the prescribed diet and exercise (51.8%). This resulted from other factors in the study, since higher body mass index and depression with low anxiety can be used to predict less adherence to the prescribed exercise.
The researchers were able to draw clinical implications from their data. They recommended more personalized rehabilitative care due to the large presence of MCI, as well as cognitive behavioral therapy to prevent psychological difficulties from interfering with adherence.
“Finally, a self-report tool enabling heath workers to assess both pharmacological and nonpharmacological adherence, such as ASiCOLD, may allow them to focus on these aspects with indisputable advantages for a patient-centered and personalized pulmonary rehabilitative intervention for COPD patients,” the researchers wrote.
The study suggests further studies to be performed due to the limited sample size and to investigate other specific clinical characteristics of the population.
Patient-Reported Outcomes Help to Uncover Frailty Patterns in Those With Acute COPD Exacerbations
April 22nd 2024Study findings demonstrate the pivotal role of patient-reported outcomes in identifying frailty among individuals experiencing acute exacerbations of chronic obstructive pulmonary disease (COPD).
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Study: Decreased BMI Increases Severe Exacerbation, All-Cause Mortality Risk in Patients With COPD
April 10th 2024Decreased body mass index (BMI) in patients with chronic obstructive pulmonary disease (COPD) was linked to a higher risk of severe exacerbations and all-cause mortality, emphasizing the importance of monitoring BMI for managing COPD and predicting outcomes.
Read More
Dose-Escalation, Low-Dose Regimens May Improve Roflumilast Treatment Adherence in Patients With COPD
March 24th 2024This study suggests that dose-escalation or low-dose regimens for roflumilast treatment in patients with chronic obstructive pulmonary disease (COPD) may improve adherence.
Read More
Patient-Reported Outcomes Help to Uncover Frailty Patterns in Those With Acute COPD Exacerbations
April 22nd 2024Study findings demonstrate the pivotal role of patient-reported outcomes in identifying frailty among individuals experiencing acute exacerbations of chronic obstructive pulmonary disease (COPD).
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Study: Decreased BMI Increases Severe Exacerbation, All-Cause Mortality Risk in Patients With COPD
April 10th 2024Decreased body mass index (BMI) in patients with chronic obstructive pulmonary disease (COPD) was linked to a higher risk of severe exacerbations and all-cause mortality, emphasizing the importance of monitoring BMI for managing COPD and predicting outcomes.
Read More
Dose-Escalation, Low-Dose Regimens May Improve Roflumilast Treatment Adherence in Patients With COPD
March 24th 2024This study suggests that dose-escalation or low-dose regimens for roflumilast treatment in patients with chronic obstructive pulmonary disease (COPD) may improve adherence.
Read More
2 Commerce Drive
Cranbury, NJ 08512